The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
|Webcasts|August 28, 2020
The Future of Precision Medicine: How Biomarkers Have Influenced Clinical Trial Designs and Outcomes
Author(s)Clarivate Cortellis
Planning a clinical trial for precision medicine is markedly more challenging than more conventional treatments, as it must consider patients' variability in genes. Join our webinar to learn how to design a successful precision medicine trial. Live: Wednesday, Oct. 14, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST On demand available after airing until Oct. 14, 2021.
Register free:
Event Overview:
Precision medicine has proven to be successful in treating cancers as it is tailored to a patient’s specific needs. Because of this custom approach to treatment, however, planning a clinical trial for precision medicine is markedly more challenging than more conventional treatments, as it must consider patients' variability in genes. As a result, biomarker use in precision medicine has been critical for defining patient segments, selecting trial locations and measuring trial success.
In this webinar, we look to learn from past precision medicine trials to provide insights on:
- The history of biomarkers in oncology
- The evolution of biomarker use in non-oncology related diseases
- The future of digital biomarkers in precision medicine
- Site identification and selection based on site experience working with specific biomarkers
Key Learning Objectives:
- What can we learn from historic precision medicine trials to guide confident trial planning in other therapy areas?
- What can we learn from use of biomarkers in oncology trials?
- How has the use of biomarkers in non-oncology trials evolved?
- What does the future hold for the use of digital biomarkers in precision medicine?
Speakers: Ketan Patel, VP, Cortellis Product Platform, Clarivate
Kinsi Oberoi, Solutions Consultant, Clarivate
Time and date: Wednesday, Oct. 14, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
On demand available after airing until Oct. 14, 2021.
Sponsor: Clarivate Cortellis
Register free:
Related to this article
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Syneos Health and Optum outline a joint model for trial planning, recruitment and site access, with no financial terms or timelines disclosed.
AstraZeneca and Oracle Outline AI Collaboration for Clinical Trial Recruitment and Safety Monitoring
What sponsors and sites should know about the AstraZeneca-Oracle AI collaboration on trial recruitment, safety monitoring and data governance.
Trending on Applied Clinical Trials Online
1
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
2
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
3
Where AI Governance in Clinical Development Falls Short
4
Syneos Health, Optum Partner on Adaptive Clinical Development Model
5